Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Windtree Therapeutics Q3 EPS $(1.08) Up From $(211.38) YoY

Author: Benzinga Newsdesk | November 19, 2025 07:23pm
Windtree Therapeutics (OTC:WINT) reported quarterly losses of $(1.08) per share. This is a 99.49 percent increase over losses of $(211.38) per share from the same period last year.

Posted In: WINT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist